Markov Modeling Analysis of Health and Economic Outcomes of Therapy With Valsartan Versus Amlodipine in Patients With Type 2 Diabetes and Microalbuminuria

OBJECTIVES: To estimate 8-year health and economic outcomes of the angiotensin II receptor blocker valsartan versus the calcium channel blocker amlodipine in therapy of patients with type 2 diabetes and microalbuminuria based on clinical endpoints from a 6-month randomized controlled clinical trial,...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Dean G., Nguyen, Anh B., Peak, Corey N., Frech, Feride H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2004
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437959/
https://www.ncbi.nlm.nih.gov/pubmed/14720103
http://dx.doi.org/10.18553/jmcp.2004.10.1.26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437959/
https://www.ncbi.nlm.nih.gov/pubmed/14720103
http://dx.doi.org/10.18553/jmcp.2004.10.1.26

Ejemplares similares